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ABSTRACT
Background Ciliopathies are an extensive group of
autosomal recessive or X-linked disorders with
considerable genetic and clinical overlap, which
collectively share multiple organ involvement and may
result in lethal or viable phenotypes. In large numbers of
cases the genetic defect remains yet to be determined.
The aim of this study is to describe the mutational
frequency and phenotypic spectrum of the CEP120 gene.
Methods Exome sequencing was performed in 145
patients with Joubert syndrome ( JS), including 15
children with oral-facial-digital syndrome type VI (OFDVI)
and 21 Meckel syndrome (MKS) fetuses. Moreover,
exome sequencing was performed in one fetus with
tectocerebellar dysraphia with occipital encephalocele
(TCDOE), molar tooth sign and additional skeletal
abnormalities. As a parallel study, 346 probands with a
phenotype consistent with JS or related ciliopathies
underwent next-generation sequencing-based targeted
sequencing of 120 previously described and candidate
ciliopathy genes.
Results We present six probands carrying nine distinct
mutations (of which eight are novel) in the CEP120
gene, previously found mutated only in Jeune
asphyxiating thoracic dystrophy ( JATD). The CEP120-
associated phenotype ranges from mild classical JS in
four patients to more severe conditions in two fetuses,
with overlapping features of distinct ciliopathies that
include TCDOE, MKS, JATD and OFD syndromes. No
obvious correlation is evident between the type or
location of identiﬁed mutations and the ciliopathy
phenotype.
Conclusion Our ﬁndings broaden the spectrum of
phenotypes caused by CEP120 mutations that account
for nearly 1% of patients with JS as well as for more
complex ciliopathy phenotypes. The lack of clear
genotype–phenotype correlation highlights the relevance
of comprehensive genetic analyses in the diagnostics of
ciliopathies.
INTRODUCTION
Ciliopathies are an extensive group of autosomal
recessive or X-linked disorders caused by defects of
the primary cilium, a highly conserved subcellular
organelle found in most vertebrate cell types.
Pathogenic mutations in genes required for proper
processes involved at the primary cilium lead to dis-
orders among which are cystic kidneys, retinal
degeneration, intellectual disability, infertility and
skeletal alterations. There is considerable genetic
and clinical overlap among distinct ciliopathy syn-
dromes that collectively share multiple organ
involvement and may result in lethal or viable
phenotypes.1
One of the most frequent ciliopathies is Joubert
syndrome ((JS) MIM213300) that is uniquely char-
acterised by a malformation of the cerebellum and
brainstem known as the ‘molar tooth sign’ (MTS).
This feature is deﬁned by an abnormally deep inter-
peduncular fossa, elongated, thick and maloriented
superior cerebellar peduncles and absent or hypo-
plastic cerebellar vermis, together giving the
appearance of a ‘molar tooth’ on axial brain MRI
through the junction of the midbrain and hindbrain
(isthmus region). Besides this pathognomonic
feature, the clinical and neuroimaging phenotype
of JS and related disorders is heterogeneous, with
frequent involvement of retina, kidneys, liver and
skeleton and variable occurrence of additional
brain malformations such as polymicrogyria,
corpus callosum dysgenesis, occipital encephalocele
and tectal dysplasia.2–4 The association of tectal
and cerebellar dysraphia with occipital encephalo-
cele (TCDOE) was ﬁrst described by Friede in
1978.5 Only a handful of cases with TCDOE have
been reported so far in the literature and the under-
lying genetic mechanism remains undetermined.
Based on conventional neuroimaging and diffusion
tensor imaging ﬁndings, TCDOE was recently sug-
gested to be part of the JS spectrum.6
The severe end of the range of ciliopathies is repre-
sented by Meckel syndrome ((MKS), MIM249000),
a lethal disorder characterised by cystic dysplastic
kidneys, bile duct proliferation of the liver, occipital
encephalocele, postaxial polydactyly, pulmonary
hypoplasia due to oligohydramnios and occasional
skeletal involvement such as bowing of long bones.7
Of the 12 genes identiﬁed as causative of MKS, 9 are
also associated with JS.8 In addition, several families
with occurrence of JS and MKS in the same sibship
have been reported,9 10 which conﬁrms that MKS
and JS are allelic disorders.
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Despite the impressive acceleration in gene discovery pro-
vided in recent years by the advent of exome sequencing, it is
estimated that the currently known ciliopathy genes are respon-
sible only for approximately 55%–60% of JS and up to 70% of
patients with MKS,2 11 while a genetic diagnosis is not reached
in the remaining individuals.
Recently, mutations in CEP120 were reported in four indivi-
duals diagnosed with Jeune asphyxiating thoracic dystrophy
( JATD), a skeletal ciliopathy.12 Here we report the identiﬁcation
of mutations in the CEP120 gene in a spectrum of phenotypes
ranging from mild classical JS to more severe conditions with
overlapping features of distinct ciliopathies that include MKS,
JATD and oral-facial-digital (OFD) syndromes. In addition, we
propose CEP120 mutations as a genetic cause of TCDOE.
PATIENTS AND METHODS
Patients
Two large cohorts of patients with a diagnosis of JS or MKS
were selected at The Rockefeller University (New York, USA)
and the CSS-Mendel Institute (Rome, Italy). The unique inclu-
sion criterion for JS was the presence of the MTS on neuroima-
ging; MKS was diagnosed in presence of at least two of the
classical signs (occipital encephalocele, renal cystic dysplasia,
postaxial polydactyly) and a normal karyotype. Detailed clinical
data were obtained from the referring clinicians who ﬁlled in a
standardised questionnaire. Neuroimaging studies were qualita-
tively reviewed for the presence of supratentorial and infraten-
torial morphological brain anomalies. All families provided
written informed consent, according to institutional guidelines.
Ethics approval has been obtained by the Ethics Committees of
the Rockefeller University, the IRCCS Casa Sollievo della
Sofferenza Institute and the UZ Leuven.
Exome sequencing
Exome sequencing was performed in 145 patients with JS,
including 15 children with OFD syndrome type VI (OFDVI),
and in 21 MKS fetuses. Moreover, exome sequencing was per-
formed in one fetus with TCDOE, the MTS and additional skel-
etal abnormalities.
In solution, exome capture was carried out using the
SureSelect Human All Exome 50 Mb Kit (Agilent Technologies,
Santa Clara, California, USA) with 150 bp paired-end read
sequences generated on a HiSeq2000 (Illumina, San Diego,
California, USA). Sequences were aligned to hg19 and variants
identiﬁed through the Genome Analysis Toolkit (GATK) pipe-
line.13 Variations were annotated with in-house software and the
SeattleSeq server.14 Identiﬁed variants were checked against
public databases dnSNP146, Exome Variant Server and ExAC.
Currently known JS, MKS and OFD genes were speciﬁcally ana-
lysed for the presence of pathogenic mutations.
Target resequencing of 120 ciliary genes
In order to assess the mutational frequency and phenotypic
spectrum of CEP120 mutations, this gene was included in a
panel of 120 previously described and candidate ciliopathy
genes (among which all known JS, MKS and OFD genes) used
for next-generation sequencing-based targeted sequencing in a
cohort of 346 probands with a phenotype consistent with JS or
related ciliopathies. Targeted resequencing was performed on a
Solid 5500xL platform using the TargetSeq Custom Enrichment
System (Thermo Fisher Scientiﬁc), according to manufacturers’
protocols. Brieﬂy, DNA libraries were fragmented and coupled
with speciﬁc adaptors, enriched for the set of genes of interest,
barcoded for pooling and then ampliﬁed by emulsion PCR,
prior to high-throughput sequencing. Variants were detected by
means of the HaplotypeCaller software package of the GATK
suite and ﬁltered so that to include only variants covered by at
least 20 reads and with mapping quality values exceeding a
Phred-score of 30. Variants reported as validated polymorph-
isms with minor allele frequency (MAF) of ≥0.01 in publicly
available human variation resources (dbSNP146, 1000
Genomes, National Heart, Lung, and Blood Institute Exome
Sequencing Project Exome Variant Server (EVS)) as well as var-
iants present in in-house control individuals with MAF of ≥0.01
were ﬁltered out.
Validation of CEP120 variants
All identiﬁed CEP120 variants were veriﬁed by bidirectional
Sanger sequencing in the proband as well as available family
members, to check segregation with the disease and carrier
status of the respective parents. Potential pathogenicity was pre-
dicted using the software tools SIFT, PolyPhen-2, PROVEAN
and Mutation Assessor. Conservation of affected residues was
assessed by the Clustal Omega software. Reference sequences
applied were CEP120 gene, NM_153223.3, CEP120 protein
and NP_694955.2. All identiﬁed variants have been submitted
to the Leiden Open (source) Variation Database (LOVD) gene
variant database.
Websites for all software and databases are listed in online
supplementary resources section.
RESULTS
Identiﬁcation of CEP120 mutations
Biallelic mutations in the CEP120 gene were identiﬁed in four
probands with JS and two fetuses with overlapping ciliopathy
phenotypes, all segregating with the disease within the families
(ﬁgure 1A, B; three variants were present in homozygous and
six in compound heterozygous state). Overall, nine distinct
mutations were detected in this study, two of which were pre-
dicted to result in a truncated protein (one nonsense mutation
and one 1 bp deletion). One of the variants comprised a splice-
site mutation and the remaining six were missense mutations
affecting highly conserved residues, all consistently predicted to
be deleterious by four distinct in silico predictors (see ﬁgure 1C
and online supplementary table S1). One of the missense muta-
tions identiﬁed in this study (p.Ala199Pro) was previously
reported by Shaheen and collaborators.12 Seven out of nine
mutations were absent from the public reference databases
(dbSNP, EVS and ExAC), while two of them (p.Ala199Pro and
p.Leu712Phe) were found in dbSNP (rs114280473 and
rs367600930, respectively), ExAC or EVS, however, at very low
frequency (MAF<0.5%) and never in a homozygous state. All
identiﬁed mutations were absent from our combined in-house
database.
Interestingly, one of the mutations consisted of a homozygous
intronic deletion leading to intron retention in family MTI-991.
Located at 5 bp from the splice donor site of exon 2, a 6 bp
deletion led to the use of an alternative splice site 483 bp down-
stream (c.49+5_49+10delins477), in approximately 5% of
mRNA, which was predicted to result in a truncated protein
after 14 amino acids (p.Gly+1Aspfs*14) (see online supplemen-
tary ﬁgure S1). The remaining mRNA product showed normal
splicing from exon 2 to exon 3. Mutations in the known genes
causative of JS and other ciliopathies were excluded in all
patients with CEP120 mutations.
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Clinical features of mutated subjects
The clinical and neuroimaging features of the four probands
with JS carrying CEP120 mutations are summarised in table 1
and ﬁgure 2. They all presented with a neurological phenotype
consisting of hypotonia, developmental delay and cognitive
impairment. Ataxia and neonatal breathing abnormalities were
reported in two individuals (MTI-143, MTI-1516), while
abnormal ocular movements were observed in a single family.
There was no involvement of other organs such as the retina,
kidneys, liver and skeleton.
Furthermore, mutations in CEP120 were detected in two
fetuses (table 2). The ﬁrst one (MKS-2930) received the diagno-
sis of MKS in the second trimester of pregnancy, due to the
presence of cystic dysplastic kidneys, occipital encephalocele
and polydactyly. In addition, postmortem examination after
pregnancy termination disclosed a narrow bell-shaped thorax
with short ribs, rhizomelic limb shortening, bowing of long
bones, microphthalmia, oral-facial defects (lobulated tongue
with multiple frenula and cleft soft palate), ambiguous genitalia
and anal atresia. Data on liver involvement were not available.
The second fetus (SW-476410) was diagnosed in utero with
TCDOE in the spectrum of JS, due to the presence of a subocci-
pital encephalocele, dysplastic tectum, severe hypoplasia of the
cerebellar vermis and the MTS, as shown by fetal MRI at
23 weeks of gestation. In addition, postmortem examination
revealed cleft palate, narrow thorax with short ribs and
Figure 1 Pedigrees and schematic representation of CEP120. (A) Genomic structure and mRNA transcript of CEP120 full-length isoform with 21
exons is shown. Untranslated regions (UTR’s) are represented by half-height boxes. The location of the mutations is indicated by M1–M9. (B)
Pedigrees of the affected families with ancestries of Italy (COR391), USA (MTI-143), Palestine (MTI-991), India (MTI-1516), Turkey (Meckel syndrome
(MKS)-2930) and Belgium (SW-476410), respectively, is shown demonstrating the segregation of the compound heterozygous mutations in
non-consanguineous families and homozygous mutations in consanguineous families. (C) Evolutionary conservation of affected amino acid residues
in CEP120 is shown. The mutated amino acids are indicated in grey and completely conserved in all species shown. JS, Joubert syndrome; M,
mutation; TCDOE, tectocerebellar dysraphia with occipital encephalocele. See online supplementary ﬁgure S1 for the chromatograms of mutation M1
in CEP120 (remaining mutation data not shown).
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secondary lung hypoplasia and discrete rhizomelic shortening of
limbs. Liver and kidneys were normal and no polydactyly was
observed.
DISCUSSION
We report for the ﬁrst time the occurrence of CEP120 muta-
tions in 4 out of 491 patients with JS (0.8%). Of note, all of
them presented with a mild, purely neurological phenotype,
adding CEP120 to the growing list of ciliary genes that are asso-
ciated with this relatively benign phenotype.3
Furthermore, we identiﬁed CEP120 mutations in two fetuses
(MKS-2930 and SW-476410) with more complex phenotypes
and overlapping features of distinct ciliopathies. Both showed
central nervous system malformations characterised by occipital/
suboccipital encephalocele and enlarged posterior fossa. In add-
ition, one fetus (SW-476410) showed marked hypoplasia of the
cerebellar vermis, dysplasia of the tectal plate and a posterior
protuberance of the lower brainstem.
The association of hypoplasia or agenesis of the cerebellar
vermis, tectal malformation (reminiscent of the tectal beaking
characteristic of the Chiari type 2 malformation) and occipital
encephalocele was ﬁrst described by Padget and Lindburg in
1972.15 In 1978, Friede introduced the term ‘tectocerebellar
dysraphia with occipital encephalocele’ (TCDOE) to describe
this constellation of ﬁndings.5 To our knowledge, in literature
this entity has only been described as a clinical diagnosis in
eight cases.6 16–21 Neuroimaging studies showed elongated and
horizontally orientated superior cerebellar peduncles reminis-
cent of the MTS in all reported patients and a deepened inter-
peduncular fossa in three of them. In addition, diffusion tensor
imaging in one child revealed absence of the decussation of the
cerebellar peduncles, as previously shown in patients with JS.4–6
In the fetus SW-476410, the suboccipital encephalocele was
located at the level of the foramen magnum. This is an unusual
location for encephalocele and has previously been reported
only in JS.4 22 Furthermore, in another published case, TCDOE
was associated with a congenital heart disease and situs inversus,
reinforcing the hypothesis of an underlying ciliopathy.21
However, no causative genes for the TCDOE phenotype had
been found to date and, to our knowledge, this is the ﬁrst
report of mutations in a ciliary gene being causative of this
exceptional condition. The ﬁnding of mutations in CEP120 in
one fetus with TCDOE further supports the observation that
TCDOE represents a morphological phenotype within the spec-
trum of JS.
Interestingly, both CEP120-mutated fetuses showed a small,
bell-shaped thorax with short ribs and rhizomelic shortening of
limbs, which are typical features of the skeletal ciliopathy
known as JATD. Besides these malformations, the typical JATD
phenotype is characterised by polydactyly, cystic dysplastic
kidneys and bile duct proliferation of the liver, all features that
are also found within the spectrum of MKS.23 However, only
one of the fetuses presented with postaxial and preaxial poly-
dactyly and cystic kidneys and therefore was initially diagnosed
with MKS.
The co-occurrence of JS and the core signs of JATD (mainly a
small thorax with secondary respiratory distress), was previously
described in some living patients.23 In addition, mutations in
two genes, CSPP1 and KIAA0586, were reported to cause both
JS and JATD, either isolated or in variable combination.24–31
Recently, a founder missense mutation of CEP120 (p.
Ala199Pro) was identiﬁed in four Saudi Arabian families
Table 1 Clinical, neuroimaging and genetic features of children with JS having CEP120 mutations
Family COR391 MTI-143 MTI-991 MTI-1516
Affected individuals (sex) 1 (F) 1 (M) 1 (M) 1 (F)
Age at last examination 4 years+7 months 11 years 2 years+1 month 2 years
Consanguinity Yes No Yes No
Country of origin Italy USA Palestine India
Nucleotide change c.581T>C hom c.2177T>C/c.2134C>T c.(49+5_49+10del; 49+5_49+
10delins477) hom
c.1138_1139insA/c.1646C>T
Protein change p.Val194Ala hom p. Leu726Pro/p.Leu712Phe p.(Gly+1Aspfs*14;?) p.Ser380Thrfs*19/p.Ala549Val
LOVD screening ID 00058830 00058831 00058832 00058833
LOVD individual ID 0000058794 0000058793 0000058796 0000058797
Neurological signs
Hypotonia Yes Yes Yes Yes
Developmental delay/cognitive impairment Yes Yes Yes Yes
Abnormal breathing No Yes No Yes
Abnormal ocular movements No OMA, nystagmus,
Duane syndrome
No Strabismus
Truncal ataxia Yes No Yes No
Other organ involvement
Retinal No No No No
Renal No No* No No
Hepatic No No No No
Oral-facial No No No No
Skeletal No No No No
Neuroimaging
Molar tooth sign Yes Yes Yes Yes
Other Mild ventriculomegaly CC hypoplasia No No
*Grade II-III hydronephrosis was detected at birth but it spontaneously resolved after few months. No renal problems have been reported since then.
CC, corpus callosum; F, female; JS, Joubert syndrome; LOVD, Leiden Open (source) Variation Database; M, male; OMA, ocular motor apraxia.
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presenting the full-blown JATD phenotype, associated with cere-
bellar vermis hypoplasia in two patients and MTS in one of
them.12 Remarkably, despite his Flemish origin without Arabian
ancestors, one fetus in the present study (SW-476410) was
found to carry the same founder mutation in combination with
a nonsense mutation, leading to the hypothesis that this particu-
lar mutation might predispose to the development of skeletal
defects.
Noteworthy, the two fetuses with JATD features in our study
also showed oral-facial defects including cleft lip, tongue hamar-
tomas and biﬁd or lobulated tongue. These oral-facial ﬁndings
were also reported in three of four CEP120-mutated patients
with JATD reported previously, suggesting that they may be
commonly associated with the skeletal phenotype and speciﬁc
to CEP120 mutations in both lethal or surviving cases.
The co-occurrence of features, each of which typical of distinct
ciliopathies (short rib polydactyly, JS/MKS spectrum and OFD
syndromes) in the same patient is an intriguing ﬁnding that has
already been reported in the literature. For instance, Thomas
and collaborators identiﬁed mutations in the TCTN3 gene in
individuals with classical JS and in fetuses with Mohr–Majewski
syndrome (also called OFD IV): an extremely severe condition
characterised by oral-facial features, polydactyly, encephalocele
and MTS, as well as renal, hepatic and skeletal anomalies.32
Moreover, patients with JS can also present oral-facial defects
and polydactyly (mainly preaxial and mesoaxial), a rare associ-
ation termed OFDVI.33 So far, mutations in TMEM216, OFD1
and C5Orf42 were found mutated in a minority of patients with
OFDVI.9 34–37 In the present study, CEP120 was sequenced in a
cohort of 15 patients with OFDVI negative for mutations in
currently known JS genes, but no pathogenic mutations were
identiﬁed. This result suggests that CEP120 may have little con-
tribution to this speciﬁc JS phenotype.
Cep120 is a centrosomal protein that is essential for micro-
tubule organisation and centriolar assembly and elongation.38 39
In mouse fetal brain, Cep120 is expressed in neural progenitors
during neocortical development and plays an important role in
neuronal migration and maintenance of the neural progenitor
pool.40 Its downregulation alters microtubule organisation and
centrosome motility, with consequent defective axonal growth
and impaired neuronal migration.41 Accordingly, the conditional
ablation of Cep120 in the mouse central nervous system led to
Figure 2 Neuroimaging or neuropathological ﬁndings of probands with CEP120 mutations are shown. Upper panel: Sagittal T1-weighted and axial
T1-weighted/coronal ﬂuid attenuation inversion recovery MRIs of a healthy subject and patients with Joubert syndrome ( JS) having CEP120
mutations show thickened and maloriented superior cerebellar peduncle (upper arrows in MTI-991-2-3 and MTI-143-2-1), rostral shifting of the
fastigium of the fourth ventricle (upper arrow in COR391), deepened interpeduncular fossa and constituting the ‘molar tooth sign’ (circled). Lower
panel: SW-476410: axial and midsagittal T2-weighted fetal MRIs at 23 weeks of gestation show a suboccipital encephalocele (arrow on the axial
image), severe hypoplasia of the cerebellar vermis and tectal dysplasia (upper arrow on the sagittal image) consistent with the diagnosis of
tectocerebellar dysraphia with occipital encephalocele (TCDOE). In addition, enlargement of the posterior fossa and dorsal protuberance of the lower
brainstem (lower arrow on the sagittal image) are noted; Meckel syndrome (MKS)-2930-2-1: a fetogram after termination of pregnancy in the
second trimester reveals a marked abdominal distention, a narrow bell-shaped thorax with short ribs, rhizomelic limb shortening and bowing of long
bones.
612 Roosing S, et al. J Med Genet 2016;53:608–615. doi:10.1136/jmedgenet-2016-103832
Developmental defects
aberrant centriolar duplication, failed ciliogenesis and altered
Sonic Hedgehog pathway activity in the granule neuron pro-
genitors, resulting in hydrocephalus and severe cerebellar hypo-
plasia.42 In addition, splice-blocking morpholino injected
zebraﬁsh knocking down Cep120 presented with a range of phe-
notypes including a centrally curved tail, hydrocephalus, otolith
defects and craniofacial defects.12
Of note, Cep120 was found to interact with Talpid3,42 the
homologue of human KIAA0586, in which mutations give rise
to a similar spectrum of ciliopathies, ranging from a mild, pure
JS to a more complex phenotype with overlapping features of
JS and JATD.27–31 This increasing range of phenotypes asso-
ciated with mutations in one and the same gene argues for the
need of broad next-generation sequencing-based approaches, to
allow the detection of novel, rare phenotypes associated with
ciliary gene mutations.
The mechanism through which mutations in the same gene
may cause such wide phenotypic variability remains unex-
plained. Genotype–phenotype correlations have been proposed
for ciliopathy genes such as TMEM67, in which two
loss-of-function mutations were found to cause MKS while the
presence of at least one hypomorphic mutation resulted in non-
lethal phenotypes.43 However, this is not obvious for CEP120,
as the MKS fetus (MKS-2930) was homozygous for a missense
mutation, while at least one JS patient (MTI-991) carried a
splice-site mutation that was shown to introduce a premature
stop codon in part of the product. Growing evidence is demon-
strating that ciliopathies might undergo an oligogenic mode of
inheritance and that heterozygous mutations in distinct genes
can modulate the clinical expression of the main recessive muta-
tions. For instance, the common variant p.Arg830Trp in the
AHI1 gene was found to signiﬁcantly enhance the frequency of
retinal disease in patients with NPHP1-associated nephro-
nophthisis.44 The identiﬁcation of such genetic modiﬁers, as
well as of other factors able to inﬂuence the penetrance and
expression of ciliary gene mutations, represents one of the
biggest challenges of current research on ciliopathies, with sig-
niﬁcant implications for diagnosis, management and counselling
of patients and their families.
In conclusion, this study adds CEP120 to the growing list of
causative genes for a variety of clinically distinct but overlapping
ciliopathies. In addition, we provide the primary molecular
diagnosis in a case of TCDOE and conﬁrm the classiﬁcation of
this morphological phenotype within the spectrum of JS.
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Database; MKS, Meckel syndrome; n.a., not available.
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